FDA Approves DxTerity's At-Home Test for Companies Trying to Make Work Safe

Breanna De Vera

Breanna de Vera is dot.LA's editorial intern. She is currently a senior at the University of Southern California, studying journalism and English literature. She previously reported for the campus publications The Daily Trojan and Annenberg Media.

FDA Approves DxTerity's At-Home Test for Companies Trying to Make Work Safe

The Food and Drug Administration approved genomics company DxTerity's at-home COVID test this week making the Rancho Dominguez-based company one of the few that partner exclusively with corporations to provide saliva-based tests that can be taken on your couch.

As workers return to work, businesses have been scrambling to create safety protocols and make workers feel safe. Individual consumers have been able to purchase at-home tests online, but the company said it hasn't been as easy for businesses.

"Our new at-home test provides the flexibility and reliability of results for people who are traveling, returning to work or simply want to ensure they can protect themselves and others," said Bob Terbrueggen, CEO of DxTerity, in a statement.

Companies can order testing kits given emergency use approval as part of their return-to-work program, and send them directly to employees' homes. Employees get results from DxTerity's lab within 48 hours of returning the sample. The company said it serves 150 company sites around the nation with more than 300,000 employees.

"What that translates to is corporations in Los Angeles, Hollywood movie studios, production companies — they can order testing directly from us for their employees to facilitate a safe return to work program, but also know they won't be impacting negatively testing available for the community," said Brett Swansiger, chief commercial officer.

The company is one of only four tests that are authorized to screen asymptomatic individuals for COVID. Such testing has to be much more sensitive to be able to catch infections even before symptoms develop. The other authorized testing for asymptomatic individuals is provided by Hologic, LabCorp and Kaiser Permanente.

Founded in 2006, DxTerity specializes in RNA monitoring for regular disease activity, but pivoted to coronavirus testing during the pandemic. It now has the capacity to process more than 10,000 samples daily of their RNA test.

The company offers businesses repeated employee screening once they return to work. The testing helps find workers who might have been infected and have the potential to spread the virus.

"Models certainly suggest that regular testing is one component of a good strategy for slowing the spread of COVID-19," said Nathaniel Bottman, a researcher at USC specializing in optimizing group testing for the virus.

Xencor, a biologic therapeutic company based in Monrovia, has one such agreement with DxTerity. Each of its 200 employees, 40% of which work on site, was tested on Memorial Day and has continued being tested weekly. Employees can also request additional testing, all of which is covered by Xencor.

DxTerity said they are in a good position as flu season rolls around and more people with flu-like symptoms test for COVID. Unlike laboratories that service hospitals, which may see a crush of new cases that slow processing, they maintain a more predictable caseload.

"It's anticipated that we're going to have 50 million people diagnosed with the flu this year, based on last year's incidents. If you put those 50 million people in the current testing pathway, along with COVID-19, all of those individuals will have to be treated as COVID-19 patients until proven otherwise," said Swansiger. "So that's going to create a huge surge in testing demand, which can prolong testing turnaround time."

According to the Center for Disease Control and Prevention COVID-19 Data tracker, there have been 137 million reported COVID-19 tests conducted this year.

Subscribe to our newsletter to catch every headline.

How AgTech Startup Leaf Wants To Modernize the Farming Industry

Samson Amore

Samson Amore is a reporter for dot.LA. He holds a degree in journalism from Emerson College and previously covered technology and entertainment for TheWrap and reported on the SoCal startup scene for the Los Angeles Business Journal. Send tips or pitches to samsonamore@dot.la and find him on Twitter @Samsonamore.

green leaf drawing and rolling farm lands
Evan Xie

At least 50,000 acres in the state of California are estimated to be underwater after a record-breaking year of rainfall. So far this year, California has received nearly 29 inches of rain, with the bulk being dumped on its central and southern coasts. Farmers are already warning that the price of dairy, tomatoes and other vegetables will rise as the weather prevents them from re-seeding their fields.

While no current technology can prevent weather disasters, Leaf Agriculture, a Los Angeles-based startup that launched in 2018, wants to help farmers better manage their properties by leveraging data.

Read moreShow less

Two LA Startups Participate in Techstars' 2023 Health Care Accelerator

Decerry Donato

Decerry Donato is a reporter at dot.LA. Prior to that, she was an editorial fellow at the company. Decerry received her bachelor's degree in literary journalism from the University of California, Irvine. She continues to write stories to inform the community about issues or events that take place in the L.A. area. On the weekends, she can be found hiking in the Angeles National forest or sifting through racks at your local thrift store.

Two LA Startups Participate in Techstars' 2023 Health Care Accelerator
Courtesy of Techstars

Earlier this month, Techstars announced that their 2023 accelerator program will have two simultaneous cohorts–Techstars health care and L.A. As previously reported on dot.LA, Techstars has brought on board returning partners Cedars Sinai, United Healthcare, along with new partners that include UCI Health and Point32Health for its health care cohort.

“For our healthcare program, this is the first time we've had multiple partners as sponsors,” Managing Director Matt Kozlov said. “This allows us to support and mentor a wider diversity of companies than we've been able to help historically.”

The in-person program is taking place in Los Angeles and two out of the twelve companies accepted into the health care program are based in Southern California.

Read moreShow less

The Creator-To-Podcaster Pipeline Is Ready to Explode

Nat Rubio-Licht
Nat Rubio-Licht is a freelance reporter with dot.LA. They previously worked at Protocol writing the Source Code newsletter and at the L.A. Business Journal covering tech and aerospace. They can be reached at nat@dot.la.
The Creator-To-Podcaster Pipeline Is Ready to Explode
Evan Xie

It’s no secret that men dominate the podcasting industry. Even as women continue to grow their foothold, men still make up many of the highest-earning podcasts, raking in massive paychecks from ad revenue and striking deals with streaming platforms worth hundreds of millions of dollars.

But a new demographic is changing that narrative: Gen-Z female influencers and content creators.

Read moreShow less